Solifenacin (Bispec (10 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Advisory Alert: It has come to our attention ...

Antimuscarinics have remained the standard of care for patients with overactive bladder (OAB) syndrome for several decades, despite the fact that, owing to their adverse effects, these drugs are ...

NEW DELHI: Glenmark Pharmaceuticals today said the US health regulator has granted tentative approval for tablets used for treatment of overactive bladder. The company has been granted tentative ...

Shares of pharma major Glenmark Pharma rose as much as 2.5 percent intraday Thursday as it has received tentative USFDA nod for Solifenacin Succinate tablets. "Glenmark Pharmaceuticals Inc., USA has ...

NEW DELHI: Strides Pharma Science Friday said its step-down wholly-owned subsidiary has received approval from the US health regulator for Solifenacin Succinate tablets, used to treat overactive ...

New Delhi, May 21 (PTI) Drug firm Alembic Pharmaceuticals Tuesday said it has received approval from the US health regulator for Solifenacin Succinate tablets, used for treatment of overactive bladder ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Solifenacin (Soliten (10 mg)) is a urinary ...